SC
Stralem & Co Portfolio holdings
AUM
$157M
This Quarter Return
+2.55%
1 Year Return
+4.29%
3 Year Return
+25.55%
5 Year Return
+55.64%
10 Year Return
–
AUM
$915M
AUM Growth
+$915M
(-7.4%)
Cap. Flow
-$93.8M
Cap. Flow
% of AUM
-10.26%
Top 10 Holdings %
Top 10 Hldgs %
33.03%
Holding
55
New
–
Increased
1
Reduced
49
Closed
2
Top Buys
| 1 |
Gilead Sciences
GILD
|
$64.3K |
Top Sells
| 1 |
PPL Corp
PPL
|
$4.92M |
| 2 |
AT&T
T
|
$4.32M |
| 3 |
Coca-Cola
KO
|
$3.85M |
| 4 |
Dominion Energy
D
|
$3.51M |
| 5 |
Starbucks
SBUX
|
$3.27M |
Sector Composition
| 1 | Healthcare | 25.76% |
| 2 | Utilities | 10.08% |
| 3 | Energy | 9.92% |
| 4 | Consumer Staples | 9.73% |
| 5 | Communication Services | 8.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Oracle
ORCL
$633B
| $24.1M | 2.63% |
589,056
-53,035
| -8% | -$2.17M |
|
27
Schlumberger
SLB
$53.6B
| $23.3M | 2.55% |
316,382
-20,268
| -6% | -$1.49M |
|
28
Chevron
CVX
$326B
| $23.2M | 2.54% |
243,340
-19,439
| -7% | -$1.85M |
|
29
Exxon Mobil
XOM
$489B
| $22.7M | 2.48% |
271,740
-22,265
| -8% | -$1.86M |
|
30
EOG Resources
EOG
$68.8B
| $21.5M | 2.35% |
296,300
-8,983
| -3% | -$652K |
|
31
Thermo Fisher Scientific
TMO
$184B
| $19.7M | 2.16% |
139,260
-13,454
| -9% | -$1.9M |
|
32
Johnson & Johnson
JNJ
$429B
| $18.8M | 2.06% |
174,110
-16,156
| -8% | -$1.75M |
|
33
Amgen
AMGN
$154B
| $17.8M | 1.94% |
118,400
-11,893
| -9% | -$1.78M |
|
34
Abbott
ABT
$229B
| $17.5M | 1.92% |
418,965
-37,642
| -8% | -$1.57M |
|
|
CELG
35
DELISTED
Celgene Corp
CELG
| $16M | 1.74% |
159,384
-15,630
| -9% | -$1.56M |
|
36
Bristol-Myers Squibb
BMY
$96.5B
| $3.09M | 0.34% |
48,300
-23,200
| -32% | -$1.48M |
|
37
Kraft Heinz
KHC
$30.8B
| $1.48M | 0.16% |
18,800
-6,000
| -24% | -$471K |
|
38
Automatic Data Processing
ADP
$121B
| $1.39M | 0.15% |
15,500
-6,650
| -30% | -$597K |
|
39
Eli Lilly
LLY
$659B
| $1.2M | 0.13% |
16,700
| – | – |
|
40
FirstEnergy
FE
$25.1B
| $1.17M | 0.13% |
32,500
-15,900
| -33% | -$572K |
|
41
Berkshire Hathaway Class B
BRK.B
$1.08T
| $1.06M | 0.12% |
7,500
| – | – |
|
42
Costco
COST
$416B
| $867K | 0.09% |
5,500
-800
| -13% | -$126K |
|
43
Colgate-Palmolive
CL
$68.2B
| $862K | 0.09% |
12,200
-4,800
| -28% | -$339K |
|
44
International Flavors & Fragrances
IFF
$17.1B
| $853K | 0.09% |
7,500
-2,100
| -22% | -$239K |
|
45
Southern Company
SO
$101B
| $833K | 0.09% |
16,100
-100
| -0.6% | -$5.17K |
|
|
46
Gilead Sciences
GILD
$140B
| $827K | 0.09% |
9,000
+700
| +8% | +$64.3K |
|
47
Zimmer Biomet
ZBH
$20.8B
| $821K | 0.09% |
7,700
-1,650
| -18% | -$176K |
|
48
Agilent Technologies
A
$35.6B
| $805K | 0.09% |
20,200
-8,600
| -30% | -$343K |
|
49
Apple
AAPL
$3.41T
| $763K | 0.08% |
7,000
| – | – |
|
50
RTX Corp
RTX
$212B
| $661K | 0.07% |
6,600
-500
| -7% | -$50.1K |
|